West conference in San Diego, California, this week, industry experts discussed how rapid advancements in AI technology are ...

The biotech firm says that its platform will help reduce the production costs of notoriously pricey gene therapies.

The firm promises to produce millions of vaccine doses to in the case of an influenza pandemic.

A research team from London examined the relationship between adenovirus-associated virus (AAV)-based vectors and liver ...

“Gilead has confirmed to us its intention to support manufacturing in South Africa,” Unitaid director of program Robert Matiru told BioProcess Insider. “This initiative will help identify capable ...

Last month, large pharmaceutical conglomerate Merck filed a worker adjustment and retraining notification (WARN) notice with ...

Eppendorf experts discuss regulatory challenges, single-use technologies, and digitalization strategies for scaling from R&D to commercial manufacturing.

Explore the latest news and expert commentary by Lakshmana Kumar Arlagadda, brought to you by the Contributor of BioProcess ...

Ireland’s biopharmaceutical sector continues to thrive amid key financial incentives, proximity to key markets, and favorable regulatory frameworks.

Modernizing biomanufacturing methods and reducing regulatory burdens are key landmarks on India’s roadmap for expanding biosimilars development.

IDBS Polar unifies ELN, LIMS, and LES in one GxP-ready platform, transforming lab data into AI-ready insights across the entire product lifecycle.

The biopharmaceutical industry is at the forefront of technological advancements, with “biopharma 4.0” revolutionizing the way biomanufacturing is conducted (1). The concept combines automation, ...